Literature DB >> 28742453

Complete Serologic Response to Pembrolizumab in a Woman With Chemoresistant Metastatic Choriocarcinoma.

Marilyn Huang1, Andre Pinto1, Rosa Patricia Castillo1, Brian M Slomovitz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28742453     DOI: 10.1200/JCO.2017.74.4052

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

Review 1.  Advances in immunotherapy and molecular targeted therapy of gestational trophoblastic tumor: current practice and future perspectives.

Authors:  Suzhu Chen; Taiping Li; Lijuan Meng; Kangsheng Liu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

2.  Effectiveness and Safety of Toripalimab Combination Therapies for Patients With Chemo-Resistant Choriocarcinoma.

Authors:  Xiaomei Liu; Xiuqin Li; Hui Qu; Shiyue Zhang; Ruizhe Zhang; Zhenhua Du
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

3.  Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center.

Authors:  Young Sok Ji; Se Hoon Park
Journal:  Cancer Res Treat       Date:  2020-12-07       Impact factor: 4.679

Review 4.  Treatment of gestational trophoblastic disease in the 2020s.

Authors:  James J Clark; Susanna Slater; Michael J Seckl
Journal:  Curr Opin Obstet Gynecol       Date:  2021-02-01       Impact factor: 2.211

5.  Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia.

Authors:  Eduardo Paulino; Andreia Cristina de Melo
Journal:  J Gynecol Oncol       Date:  2019-04-22       Impact factor: 4.401

6.  Treatment of metastatic placental site trophoblastic tumor with surgery, chemotherapy, immunotherapy and coil embolization of multiple pulmonary arteriovenous fistulate.

Authors:  A Porter; J M Barcelon; R L Budker; L Marsh; J M Moriarty; X Aguiar; J Rao; E Ghorani; B Kaur; G Maher; M J Seckl; G E Konecny; J G Cohen
Journal:  Gynecol Oncol Rep       Date:  2021-05-07

7.  Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy.

Authors:  Adriana J Wong; Lindsey Finch; Joseph Matt Pearson; Andre Pinto; Marilyn Huang
Journal:  Gynecol Oncol Rep       Date:  2022-03-09

8.  An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab.

Authors:  Sarah G Bell; Shitanshu Uppal; Michelle D Sakala; Andrew P Sciallis; Aimee Rolston
Journal:  Gynecol Oncol Rep       Date:  2021-06-23

9.  Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report.

Authors:  V Paspalj; S Polterauer; N Poetsch; A Reinthaller; C Grimm; T Bartl
Journal:  Gynecol Oncol Rep       Date:  2021-06-24

10.  A promising treatment option for refractory male primary choriocarcinoma: report of two cases.

Authors:  Chen Han; Ying Zhou; Jin-An Ma; Jia Liu; Yu-Na Jiang; Hai-Xia Zhang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.